Histological analysis provides critical information on the tumor type, grade, and molecular characteristics, which guide treatment decisions and prognosis. For example, the presence of certain genetic mutations, such as IDH1/2 in gliomas, can influence the choice of therapy and predict patient outcomes. Histological grading helps stratify the risk and tailor the treatment plan accordingly.
